These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3260689)

  • 41. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.
    Alexander EL; Arnett FC; Provost TT; Stevens MB
    Ann Intern Med; 1983 Feb; 98(2):155-9. PubMed ID: 6600593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
    Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
    Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
    J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sjögren's syndrome.
    Lee M; Rutka JA; Slomovic AR; McComb J; Bailey DJ; Bookman AA
    J Rheumatol; 1998 Feb; 25(2):247-53. PubMed ID: 9489815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies to Ro and La.
    Reichlin M
    Ann Med Interne (Paris); 1998 Feb; 149(1):34-41. PubMed ID: 11490515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel autoantibodies in Sjogren's syndrome.
    Shen L; Suresh L; Lindemann M; Xuan J; Kowal P; Malyavantham K; Ambrus JL
    Clin Immunol; 2012 Dec; 145(3):251-5. PubMed ID: 23123440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
    Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
    Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.
    Davidson BK; Kelly CA; Griffiths ID
    Rheumatology (Oxford); 1999 Mar; 38(3):245-53. PubMed ID: 10325663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Dermatological manifestations of Sjögren's syndrome].
    Ueki H; Inagaki Y; Hamasaki Y; Ono M
    Hautarzt; 1991 Dec; 42(12):741-7. PubMed ID: 1765488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study.
    Olsen ML; O'Connor S; Arnett FC; Rosenbaum D; Grotta JC; Warner NB
    Am J Med; 1991 Apr; 90(4):479-88. PubMed ID: 1901447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Value of anti-Ro antibodies in 2 cases of Sjögren's disease with multisystem involvement].
    Jaccard Y; di Stefano R; Bréaud P; Delacrétaz F; Fontolliet C; Pécoud A
    Schweiz Med Wochenschr; 1989 Jan; 119(3):84-7. PubMed ID: 2785287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An analysis of the frequency of Sjogren's syndrome in a population of multiple sclerosis patients.
    Metz LM; Seland TP; Fritzler MJ
    J Clin Lab Immunol; 1989 Nov; 30(3):121-5. PubMed ID: 2642169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An association of fibromyalgia with primary Sjögren's syndrome: a prospective study of 72 patients.
    Bonafede RP; Downey DC; Bennett RM
    J Rheumatol; 1995 Jan; 22(1):133-6. PubMed ID: 7699659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antinuclear antibodies in Sjögren's disease and syndrome].
    Kirtava ZZ; Guseva NG; Vasil'ev VI; Poverennyĭ AM; Ivanova SM
    Ter Arkh; 1986; 58(7):54-7. PubMed ID: 3490010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-centromere antibody-positive Sjögren's syndrome: A distinct clinical subgroup?
    Lee KE; Kang JH; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Lee SS
    Int J Rheum Dis; 2015 Sep; 18(7):776-82. PubMed ID: 26179502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder.
    Gerli R; Muscat C; Giansanti M; Danieli MG; Sciuto M; Gabrielli A; Fiandra E; Vitali C
    Br J Rheumatol; 1997 Sep; 36(9):969-75. PubMed ID: 9376993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study.
    Andonopoulos AP; Drosos AA; Skopouli FN; Moutsopoulos HM
    Clin Exp Rheumatol; 1989; 7(2):203-5. PubMed ID: 2736835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The immunologic processes of the etiopathogenesis of Sjögren's syndrome].
    Oğüt MS; Ergüven S; Irkeç M; Gülmezoğlu E; Ustaçelebi S
    Mikrobiyol Bul; 1988 Jan; 22(1):30-5. PubMed ID: 3078788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.